TuHURA Biosciences, Inc.
General ticker "HURA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $108.3M (TTM average)
TuHURA Biosciences, Inc. follows the US Stock Market performance with the rate: 16.2%.
Estimated limits based on current volatility of 2.5%: low 2.06$, high 2.16$
Factors to consider:
- Earnings expected soon, date: nan
- Total employees count: 22 as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Limited operating history, Inability to achieve profitability, Going concern doubt, Product development challenges, Need for additional capital
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.71$, 2.23$]
- 2026-12-31 to 2027-12-31 estimated range: [0.74$, 2.21$]
Financial Metrics affecting the HURA estimates:
- Positive: with PPE of -1.2 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -74.00 <= 0.30
- Positive: Interest expense per share per price, % of 1.67 <= 3.33
- Positive: Inventory ratio change, % of -100 <= -0.76
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: -4.44 < Investing cash flow per share per price, % of -3.58
Short-term HURA quotes
Long-term HURA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $8.45MM | $17.65MM | $31.50MM |
| Operating Income | $-8.45MM | $-17.65MM | $-31.50MM |
| Non-Operating Income | $0.13MM | $-4.03MM | $1.45MM |
| Interest Expense | $0.02MM | $4.14MM | $0.63MM |
| R&D Expense | $2.66MM | $13.34MM | $20.53MM |
| Income(Loss) | $-8.32MM | $-21.68MM | $-30.05MM |
| Net Income(Loss)* | $-8.32MM | $-21.68MM | $-30.06MM |
| Stockholders Equity | $-1.56MM | $14.59MM | $20.93MM |
| Inventory | $0.00MM | $0.21MM | $0.00MM |
| Assets | $4.36MM | $19.97MM | $27.35MM |
| Operating Cash Flow | $-11.95MM | $-14.73MM | $-27.63MM |
| Capital expenditure | $0.08MM | $0.06MM | $0.08MM |
| Investing Cash Flow | $-1.30MM | $-6.05MM | $-1.34MM |
| Financing Cash Flow | $2.66MM | $29.77MM | $19.93MM |
| Earnings Per Share** | $-11.05 | $-1.16 | $-0.63 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.